| 31722-440 | These highlights do not include all the information needed to use AVANAFIL TABLETS safely and effectively. See full prescribing information for AVANAFIL TABLETS. AVANAFIL tablets, for oral use Initial U.S. Approval: 2012 | Camber Pharmaceuticals, Inc. | Hetero Labs Limited Unit III |
| 31722-440-01 | These highlights do not include all the information needed to use AVANAFIL TABLETS safely and effectively. See full prescribing information for AVANAFIL TABLETS. AVANAFIL tablets, for oral use Initial U.S. Approval: 2012 | Camber Pharmaceuticals, Inc. | Hetero Labs Limited Unit III |
| 31722-440-30 | These highlights do not include all the information needed to use AVANAFIL TABLETS safely and effectively. See full prescribing information for AVANAFIL TABLETS. AVANAFIL tablets, for oral use Initial U.S. Approval: 2012 | Camber Pharmaceuticals, Inc. | Hetero Labs Limited Unit III |
| 31722-441 | These highlights do not include all the information needed to use AVANAFIL TABLETS safely and effectively. See full prescribing information for AVANAFIL TABLETS. AVANAFIL tablets, for oral use Initial U.S. Approval: 2012 | Camber Pharmaceuticals, Inc. | Hetero Labs Limited Unit III |
| 31722-441-01 | These highlights do not include all the information needed to use AVANAFIL TABLETS safely and effectively. See full prescribing information for AVANAFIL TABLETS. AVANAFIL tablets, for oral use Initial U.S. Approval: 2012 | Camber Pharmaceuticals, Inc. | Hetero Labs Limited Unit III |
| 31722-441-30 | These highlights do not include all the information needed to use AVANAFIL TABLETS safely and effectively. See full prescribing information for AVANAFIL TABLETS. AVANAFIL tablets, for oral use Initial U.S. Approval: 2012 | Camber Pharmaceuticals, Inc. | Hetero Labs Limited Unit III |
| 31722-442 | These highlights do not include all the information needed to use AVANAFIL TABLETS safely and effectively. See full prescribing information for AVANAFIL TABLETS. AVANAFIL tablets, for oral use Initial U.S. Approval: 2012 | Camber Pharmaceuticals, Inc. | Hetero Labs Limited Unit III |
| 31722-442-01 | These highlights do not include all the information needed to use AVANAFIL TABLETS safely and effectively. See full prescribing information for AVANAFIL TABLETS. AVANAFIL tablets, for oral use Initial U.S. Approval: 2012 | Camber Pharmaceuticals, Inc. | Hetero Labs Limited Unit III |
| 31722-442-30 | These highlights do not include all the information needed to use AVANAFIL TABLETS safely and effectively. See full prescribing information for AVANAFIL TABLETS. AVANAFIL tablets, for oral use Initial U.S. Approval: 2012 | Camber Pharmaceuticals, Inc. | Hetero Labs Limited Unit III |
| 62157-458 | AX Pharmaceutical Corp DailyMed label | AX Pharmaceutical Corp |
| 62157-458-01 | AX Pharmaceutical Corp DailyMed label | AX Pharmaceutical Corp |
| 62157-459 | AX Pharmaceutical Corp DailyMed label | AX Pharmaceutical Corp |
| 62157-459-01 | AX Pharmaceutical Corp DailyMed label | AX Pharmaceutical Corp |
| 72384-751 | These highlights do not include all the information needed to use STENDRA safely and effectively. See full prescribing information for STENDRA . STENDRA ® (avanafil) tablets, for oral use Initial U.S. Approval: 2012 | Metuchen Pharmaceuticals, LLC |
| 72384-751-30 | These highlights do not include all the information needed to use STENDRA safely and effectively. See full prescribing information for STENDRA . STENDRA ® (avanafil) tablets, for oral use Initial U.S. Approval: 2012 | Metuchen Pharmaceuticals, LLC |
| 72384-752 | These highlights do not include all the information needed to use STENDRA safely and effectively. See full prescribing information for STENDRA . STENDRA ® (avanafil) tablets, for oral use Initial U.S. Approval: 2012 | Metuchen Pharmaceuticals, LLC |
| 72384-752-01 | These highlights do not include all the information needed to use STENDRA safely and effectively. See full prescribing information for STENDRA . STENDRA ® (avanafil) tablets, for oral use Initial U.S. Approval: 2012 | Metuchen Pharmaceuticals, LLC |
| 72384-752-30 | These highlights do not include all the information needed to use STENDRA safely and effectively. See full prescribing information for STENDRA . STENDRA ® (avanafil) tablets, for oral use Initial U.S. Approval: 2012 | Metuchen Pharmaceuticals, LLC |
| 72384-752-99 | These highlights do not include all the information needed to use STENDRA safely and effectively. See full prescribing information for STENDRA . STENDRA ® (avanafil) tablets, for oral use Initial U.S. Approval: 2012 | Metuchen Pharmaceuticals, LLC |
| 72384-753 | These highlights do not include all the information needed to use STENDRA safely and effectively. See full prescribing information for STENDRA . STENDRA ® (avanafil) tablets, for oral use Initial U.S. Approval: 2012 | Metuchen Pharmaceuticals, LLC |
| 72384-753-01 | These highlights do not include all the information needed to use STENDRA safely and effectively. See full prescribing information for STENDRA . STENDRA ® (avanafil) tablets, for oral use Initial U.S. Approval: 2012 | Metuchen Pharmaceuticals, LLC |
| 72384-753-30 | These highlights do not include all the information needed to use STENDRA safely and effectively. See full prescribing information for STENDRA . STENDRA ® (avanafil) tablets, for oral use Initial U.S. Approval: 2012 | Metuchen Pharmaceuticals, LLC |
| 72384-753-99 | These highlights do not include all the information needed to use STENDRA safely and effectively. See full prescribing information for STENDRA . STENDRA ® (avanafil) tablets, for oral use Initial U.S. Approval: 2012 | Metuchen Pharmaceuticals, LLC |